Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis

被引：4
|
作者：
Wahlin, Staffan [1 ,2 ]
Efe, Cumali [3 ]
机构：
[1] Karolinska Inst, Hepatol Div, Dept Upper GI Dis, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Harran Univ, Dept Gastroenterol, Sanliurfa, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 03期
关键词：
DISEASES;
D O I：
10.1016/j.jhep.2020.09.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：753 / 755
页数：3
相关论文
共 50 条
  • [31] Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures?
    Shah, Anoop S. V.
    Eddleston, Michael
    CLINICAL TOXICOLOGY, 2010, 48 (08) : 800 - 805
  • [32] Second-line therapy in advanced biliary tract cancer: What should be the standard?
    Cereda, Stefano
    Belli, Carmen
    Rognone, Alessia
    Mazza, Elena
    Reni, Michele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (02) : 368 - 374
  • [33] Second Line Therapy in Autoimmune Hepatitis: is Mycophenolate Mofetil an effective option?
    Ploch, Philippe
    Marquardt, Jens U.
    Fritzsche, Susanne
    Krupp, Markus
    Galle, Peter R.
    Teufel, Andreas
    Barreiros, Ana P.
    HEPATOLOGY, 2012, 56 : 724A - 724A
  • [34] The Best Choice for Second-line Agent in Standard Treatment-refractory Children With Autoimmune Hepatitis
    Nastasio, Silvia
    Sciveres, Marco
    Maggiore, Giuseppe
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (03): : E86 - E87
  • [35] Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
    Huebener, Sina
    Oo, Ye Htun
    Than, Nwe Ni
    Huebener, Peter
    Weiler-Normann, Christina
    Lohse, Ansgar W.
    Schramm, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (03) : 445 - 453
  • [36] Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis
    Zizzo, Andreanne N.
    Valentino, Pamela L.
    Shah, Prakesh S.
    Kamath, Binita M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (01): : 6 - 15
  • [37] Effective Alternative for Second-Line Therapy
    不详
    OBESITY FACTS, 2009, 2 (01) : 57 - 57
  • [38] Axitinim believe in Second-Line Therapy
    Roos, Frederik
    AKTUELLE UROLOGIE, 2012, 43 (03) : 135 - 137
  • [39] Second-line therapy for esophageal cancer
    Martin, Mike G.
    Govindan, Ramoswamy
    Morgensztern, Daniel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 871 - 876
  • [40] Second-line therapy of ovarian carcinoma
    Sevelda, P
    ONKOLOGIE, 2000, 23 (06): : 593 - 596
12345